Fundraising FoxYoungheartvalve
1 known investors
Find your way into Youngheartvalve
YoungHeartValve develops a tissue-free transcatheter aortic valve replacement (TAVR) technology that integrates hyaluronan into synthetic polymer leaflets to resist thrombosis and calcification. Its fully synthetic, animal-free valve platform is designed for automated, scalable manufacturing and multiple valve indications in the structural heart intervention field.
Investors · 1
Frequently asked questions
- What does Youngheartvalve do?
- YoungHeartValve develops a tissue-free transcatheter aortic valve replacement (TAVR) technology that integrates hyaluronan into synthetic polymer leaflets to resist thrombosis and calcification. Its fully synthetic, animal-free valve platform is designed for automated, scalable manufacturing and multiple valve indications in the structural heart intervention field.
- Who are Youngheartvalve's investors?
- Youngheartvalve's investors include Colorado BioScience Association.